Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial

NCT00140179 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT00140179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial
Lead sponsor
Beersheva Mental Health Center
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
May 31, 2008
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mania, schizoaffective disorder, manic type